Blog Archives

FDA approves Albiglutide [Tanzeum] to treat type 2 diabetes

April 16, 2014 – The U.S. Food and Drug Administration (FDA)  yesterday  approved Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. Type 2 diabetes affects approximately 24 million people and accounts for more than 90 percent of diabetes cases diagnosed in the United States.

Read more ›

Tags: , , , , , , , , ,

Incretin Mimetic Drugs for Type 2 Diabetes: Early Communication – Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas

May 09, 2013 – We have just stumbled upon a recent press release to the public by the American Food and Drug Administration (FDA) on a looming drug safety problem of incretin mimetic drugs related to the pancreas. Find here the unedited press releaase in full:

[Posted 03/14/2013]

AUDIENCE: Gastroenterology,

Read more ›

Tags: , ,

Bristol-Myers gets approval for its diabetes drug Saxagliptin [Onglyza] in the European Union (EU)

October 14, 2009 – On October 5, 2009, drug maker Bristol-Myers Squibb Co. announced that its new diabetes drug, Saxagliptin [Onglyza], has been approved for sale in the European Union’s (EU) 27 countries.

Saxagliptin [Onglyza] is the first diabetes drug to be launched in Europe by a partnership of New York-based Bristol-Myers and British drugmaker AstraZeneca PLC to develop drugs for type 2 diabetes.

Read more ›

Tags: , , ,

thasso: conditions

thasso: tweets

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Releasing brakes: Potential new methods for Duchenne muscular dystrophy therapies February 24, 2020
    Researchers identified a group of small molecules that may open the door to developing new therapies for Duchenne muscular dystrophy (DMD), an as-yet-uncured disease that results in devastating muscle weakening and loss. The molecules tested by the team from the Perelman School of Medicine at the University of Pennsylvania eased repression of a specific gene, […]
  • Extra chromosomes in cancers can be good or bad February 24, 2020
    Cancer cells are notorious for their genetic disarray. A tumor cell can contain an abundance of DNA mutations and most have the wrong number of chromosomes. A missing or extra copy of a single chromosome creates an imbalance called aneuploidy, which can skew the activity of hundreds or thousands of genes. As cancer progresses, so […]
  • Researchers show that DNA topological problems may cause lymphoma February 24, 2020
    Researchers from the Spanish National Cancer Research Centre (CNIO), Madrid, and the Andalusian Molecular Biology and Regenerative Medicine Centre (Cabimer), Seville, published a paper in Nature Communications that shows that DNA topological problems may cause endogenous DNA breaks that have a causal relationship with cancer.
  • New DNA test that reveals a child's 'true age' has promise, but ethical pitfalls February 24, 2020
    Epigenetic clocks are a new type of biological test currently capturing the attention of the scientific community, private companies and governmental agencies because of their potential to reveal an individual's "true" age.
  • Mayo researchers recommend all women with breast cancer diagnosis under age 66 be offered genetic testing February 21, 2020
    A study by researchers at Mayo Clinic published this week in the Journal of Clinical Oncology suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing to determine if they have a gene mutation known to increase the risk of developing other cancers and cancers among […]
  • An 'exceptionally stable' single-atom catalyst February 24, 2020
    Scientists at Tokyo Institute of Technology (Tokyo Tech) have shown that single platinum atoms trapped in C12A7 crystals act as a stable and effective catalyst for the hydrogenation of nitroarenes, an essential process in the production of many kinds of fine chemicals. Their approach could become a versatile route for developing other single-atom catalysts for […]
  • Researchers analyze influenza epidemiologic supervision and children cases in Catalonia February 24, 2020
    Two studies led by the UB analyzed several aspects involved in the detection of the influenza: the utility of the definition of the illness considering clinical manifestation and complementarity of supervision systems based on severe ambulatory cases that require hospitalization in Catalonia. Moreover, they also studied the features of the cases that were detected in […]
  • Short film of a magnetic nano-vortex February 24, 2020
    For the first time, researchers at the Paul Scherrer Institute PSI have recorded a '3D film' of magnetic processes on the nanometer scale. This reveals a variety of dynamics inside the material, including the motion of swirling boundaries between different magnetic domains. The insights were gained with a method newly developed at the Swiss Light […]
  • Neural cells speed up function in 3D bioprinted skeletal muscle constructs February 24, 2020
    Wake Forest Institute for Regenerative Medicine scientists improve on 3D bioprinting research by investigating the effects of neural cell integration into bioprinted muscle constructs to accelerate functional muscle regeneration.
  • Mirrored chip could enable handheld dark-field microscopes February 24, 2020
    Engineers at MIT have developed a small, mirrored chip that helps to produce dark-field images, without dedicated expensive components. The chip is slightly larger than a postage stamp and as thin as a credit card. When placed on a microscope's stage, the chip emits a hollow cone of light that can be used to generate […]
Top